DAFNA Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-57,746	Closed	-$3.81M	–	74
2023 Q1	$3.81M	Sell	57,746 -25,700	-31%	-$1.48M	1.14%	28
2022 Q4	$4.31M	Buy	83,446 +17,500	+27%	+$928K	1.22%	24
2022 Q3	$4.5M	Sell	65,946 -30,989	-32%	-$1.83M	1.21%	29
2022 Q2	$4.38M	Buy	96,935 +3,000	+3%	+$137K	1.19%	26
2022 Q1	$4.77M	Buy	+93,935	New	+$4.15M	1.24%	24
2021 Q3	–	Sell	-12,703	Closed	-$803K	–	82
2021 Q2	$803K	Sell	12,703 -32,223	-72%	-$1.66M	0.17%	75
2021 Q1	$1.93M	Buy	44,926 +1,010	+2%	+$47.8K	0.46%	53
2020 Q4	$2.51M	Buy	43,916 +13,862	+46%	+$586K	0.75%	35
2020 Q3	$907K	Sell	30,054 -3,500	-10%	-$105K	0.29%	57
2020 Q2	$1.1M	Sell	33,554 -20,500	-38%	-$658K	0.32%	54
2020 Q1	$1.45M	Buy	54,054 +13,397	+33%	+$476K	0.6%	39
2019 Q4	$1.25M	Sell	40,657 -129,143	-76%	-$3.57M	0.43%	53
2019 Q3	$4.09M	Buy	+169,800	New	+$4.67M	1.54%	18